DB15800ExperimentalVaccines
VA-MENGOC-BC is a meningococcal B and C vaccine and an outer membrane vesicle (OMV)-based vaccine. The OMVs contain over 100 proteins, and are derived from meningococcal group B and capsular... As there already exists a polysaccharide-based vaccine against meningococcal disease originating from serogroups A,C,W135, and Y, this vaccine was created for use against serogroups B and C.
- Also known as
- Meningococcal polysaccharide vaccine groups B and C
- Code names
- VA-MENGOC-BC
What you can answer from here — as of March 06, 2025
Which companies are running trials of VA-MENGOC-BC®, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account